Literature DB >> 8794985

Improving the oral bioavailability of sulpiride by a gastric-retained form in rabbits.

N Kohri1, I Naasani, K Iseki, K Miyazaki.   

Abstract

To improve the limited oral bioavailability of sulpiride, a gastric-retained form was developed and evaluated using gastric-emptying-controlled rabbits. The AUC value after oral administration of sulpiride as an aqueous solution was less than that after oral administration of sulpiride original powder. The dissolution was not important as a rate limiting factor for sulpiride oral absorption. Sulpiride was absorbed predominantly from the upper part of the small intestine of the rabbit. A gastric-retained tablet prepared from Carbopol 934P, with sustained-release characteristics, was found to be suitable for improving and extending the oral bioavailability of sulpiride.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794985     DOI: 10.1111/j.2042-7158.1996.tb05935.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

Review 1.  Floating drug delivery systems: a review.

Authors:  Shweta Arora; Javed Ali; Alka Ahuja; Roop K Khar; Sanjula Baboota
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

2.  Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.

Authors:  M Baluom; M Friedman; P Assaf; A I Haj-Yehia; A Rubinstein
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

3.  Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization.

Authors:  Hesham M Tawfeek; Yasser A Hassan; Mohammed F Aldawsari; Mohamed H Fayed
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-05

4.  Novel sulpiride-loaded solid lipid nanoparticles with enhanced intestinal permeability.

Authors:  Waheed M Ibrahim; Abdullah H AlOmrani; Alaa Eldeen B Yassin
Journal:  Int J Nanomedicine       Date:  2013-12-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.